Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA-Reference-Cited by-同舟云学术

Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA

Published:2016-01-20 Issue:8 Volume:8 Page:13611-13619
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Del Re Marzia¹,Tiseo Marcello²,Bordi Paola²,D’Incecco Armida³,Camerini Andrea⁴,Petrini Iacopo⁵,Lucchesi Maurizio⁶,Inno Alessandro⁷,Spada Daniele⁸,Vasile Enrico⁶,Citi Valentina¹,Malpeli Giorgio⁹,Testa Enrica⁸,Gori Stefania⁷,Falcone Alfredo⁶,Amoroso Domenico⁴,Chella Antonio¹⁰,Cappuzzo Federico³,Ardizzoni Andrea²,Scarpa Aldo⁹,Danesi Romano¹

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

2. Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Parma, Italy

3. Medical Oncology Unit, AUSL6, Istituto Toscano Tumori, Livorno, Italy

4. Medical Oncology Unit, AUSL12, Istituto Toscano Tumori, Lido di Camaiore, Italy

5. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

6. Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria, Pisa, Italy

7. Medical Oncology Unit, Ospedale Sacro Cuore, Negrar, Italy

8. Medical Oncolgy Unit, Ospedale Santa Maria della Misericordia, Urbino, Italy

9. ARC-NET Research Centre and Department of Pathology and Diagnostics, Azienda Ospedaliero-Universitaria, Verona, Italy

10. Lung Diseases Unit, Azienda Ospedaliero-Universitaria, Pisa, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of KRAS mutation using plasma samples in non-small-cell lung cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-07-06

2. APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer;2023-07-03

3. A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine;Journal of Clinical Medicine;2023-03-01

4. Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis;Frontiers in Genetics;2022-10-25

5. Drugging KRAS: current perspectives and state-of-art review;Journal of Hematology & Oncology;2022-10-25